Trade Eisai Co., Ltd. - 4523 CFD
Add to favourite- Summary
- Historical Data
| Spread | 38.0 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.011244% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.010978% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | JPY | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Japan | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6240.5 |
| Open | 6140 |
| 1-Year Change | -19.39% |
| Day's Range | 6140 - 6219.5 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | 6219.5 | 79.5 | 1.29% | 6140.0 | 6229.7 | 6119.7 |
| Apr 25, 2024 | 6240.5 | 28.8 | 0.46% | 6211.7 | 6311.8 | 6157.2 |
| Apr 24, 2024 | 6069.1 | -11.4 | -0.19% | 6080.5 | 6154.9 | 6030.1 |
| Apr 23, 2024 | 6072.0 | 9.0 | 0.15% | 6063.0 | 6095.1 | 6024.1 |
| Apr 22, 2024 | 6077.0 | 141.1 | 2.38% | 5935.9 | 6079.1 | 5903.4 |
| Apr 19, 2024 | 5886.5 | 12.0 | 0.20% | 5874.5 | 5903.5 | 5784.8 |
| Apr 18, 2024 | 5802.7 | -70.8 | -1.21% | 5873.5 | 5893.5 | 5793.7 |
| Apr 17, 2024 | 5912.4 | -59.9 | -1.00% | 5972.3 | 5993.2 | 5897.5 |
| Apr 16, 2024 | 6023.1 | 102.7 | 1.73% | 5920.4 | 6036.1 | 5920.4 |
| Apr 15, 2024 | 5988.2 | 76.8 | 1.30% | 5911.4 | 6007.2 | 5900.4 |
| Apr 12, 2024 | 6016.2 | 41.9 | 0.70% | 5974.3 | 6027.1 | 5960.3 |
| Apr 11, 2024 | 5953.3 | 29.9 | 0.50% | 5923.4 | 5982.2 | 5906.4 |
| Apr 10, 2024 | 6004.2 | -78.8 | -1.30% | 6083.0 | 6107.9 | 5995.2 |
| Apr 9, 2024 | 6103.9 | 15.0 | 0.25% | 6088.9 | 6111.9 | 6037.1 |
| Apr 8, 2024 | 6085.0 | -35.8 | -0.58% | 6120.8 | 6150.8 | 6042.1 |
| Apr 5, 2024 | 6077.0 | 116.7 | 1.96% | 5960.3 | 6085.0 | 5954.3 |
| Apr 4, 2024 | 6037.1 | 32.9 | 0.55% | 6004.2 | 6076.0 | 5968.3 |
| Apr 3, 2024 | 5914.4 | -38.9 | -0.65% | 5953.3 | 5962.3 | 5849.6 |
| Apr 2, 2024 | 6073.0 | 45.9 | 0.76% | 6027.1 | 6110.9 | 6010.2 |
| Apr 1, 2024 | 6067.0 | -158.5 | -2.55% | 6225.5 | 6259.5 | 6044.1 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Eisai Co., Ltd. Company profile
About Eisai Co., Ltd
Eisai Co., Ltd. is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Eisai Co., Ltd revenues increased 13% to Y565.33B. Net income applicable to common stockholders increased 34% to Y60.36B. Revenues reflect Other Business segment increase from Y43.85B to Y92.54B, Pharmaceutical Business segment increase of 3% to Y449.48B, China segment increase of 25% to Y83.14B, America segment increase of 13% to Y125.19B, Asia/Latin America segment increase of 10% to Y38.04B.
Equity composition
FY'99-02 WAS & FY'04 DWAS were estimated. FY'03 DWAS was adjusted to reflect reported DEPS. FY'04-06 1Q&3Q WAS & O/S were estimated. 12/05 DPS estimated. FY'08 Q1&Q3 DWAS were estimated. FY'08 Q1&Q3 WAS = O/S. FY'11 Q3 DWAS estimated.
| Industry: | Pharmaceuticals (NEC) |
エーザイ本館
小石川4-6-10
BUNKYO-KU
TOKYO-TO 112-8088
JP
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com